Asia Pacific Sleep Apnea Devices Market Report by Types, Therapeutic Devices, End User, Countries and Companies Analysis 2026-2034

Asia Pacific Sleep Apnea Devices Market Size and Forecast 2026-2034

Asia Pacific Sleep Apnea Devices Market is expected to reach US$ 5.02 Billion by 2034 from US$ 2.41 Billion in 2025, with a CAGR of 8.5% from 2026 to 2034. The Asia Pacific sleep apnea devices market is driven by increasing awareness of sleep disorders, rising obesity rates, growing elderly populations, expanding healthcare infrastructure, and the adoption of advanced CPAP, BiPAP, and wearable sleep-monitoring technologies across both developed and emerging economies.

Asia Pacific Sleep Apnea Devices Industry Overview

Sleep apnea devices are medical technologies designed to diagnose, monitor, and treat sleep apnea, a disorder characterized by repeated interruptions in breathing during sleep. Common devices include continuous positive airway pressure (CPAP) machines, bilevel positive airway pressure (BiPAP) devices, adaptive servo-ventilation systems, oral appliances, and sleep monitoring equipment. These devices help maintain airway patency, improve oxygen flow, reduce sleep disruptions, and minimize associated health risks such as cardiovascular disease, hypertension, and daytime fatigue. Technological advancements, including cloud connectivity, AI-enabled monitoring, wearable diagnostics, and patient-friendly mask designs, are improving treatment adherence and clinical outcomes for sleep apnea patients.

The Asia Pacific sleep apnea devices market is experiencing significant growth due to the increasing prevalence of obstructive sleep apnea, rising obesity rates, and growing awareness regarding sleep-related health conditions. Expanding healthcare infrastructure and improved access to sleep diagnostic services are supporting the adoption of treatment devices across the region. Additionally, increasing healthcare expenditure and rising demand for home-based respiratory care solutions are encouraging market expansion. Technological innovations such as connected CPAP systems, digital health platforms, AI-enabled patient monitoring, and advanced mask designs are improving treatment compliance and patient comfort. These factors collectively continue to strengthen market growth across Asia Pacific countries.

Recent Developments in Asia Pacific Sleep Apnea Devices Market

• March 2025: A pilot study conducted in Australia's Northern Territory demonstrated that the General Practice Sleep Scale (GPSS)-OSA questionnaire delivered superior screening performance for obstructive sleep apnea compared with commonly used tools such as the Epworth Sleepiness Scale (ESS), Berlin Questionnaire, and OSA-50. The study findings, published in the peer-reviewed journal Sleep Medicine, highlighted the questionnaire's improved accuracy in identifying patients at risk of OSA.
• August 2024: Oxymed expanded its sleep therapy portfolio with the launch of the SleepEasy Auto CPAP, featuring the proprietary FlowSens algorithm designed to optimize therapy comfort and performance. The device was introduced through dealer networks and online channels across India, offering an affordable and durable solution for sleep apnea management.
• March 2024: An industry report highlighted regulatory challenges faced by smaller sleep apnea device manufacturers when seeking approval for innovative technologies. Devices incorporating advanced capabilities such as wireless connectivity, remote monitoring, and AI-driven therapy optimization were reported to experience longer evaluation timelines due to extensive testing requirements, creating barriers for emerging companies seeking to compete with established market participants.

Growth Drivers for the Asia Pacific Sleep Apnea Devices Market

Rising Prevalence of Sleep Disorders and Lifestyle-Related Risk Factors

The increasing prevalence of obstructive sleep apnea and other sleep-related breathing disorders is a major factor driving the Asia Pacific sleep apnea devices market. Rapid urbanization, sedentary lifestyles, rising obesity rates, smoking habits, and increasing stress levels have contributed to a growing patient population requiring diagnosis and treatment. Additionally, the region's aging population is particularly susceptible to sleep apnea, creating sustained demand for therapeutic devices. Growing awareness among healthcare professionals and patients regarding the long-term consequences of untreated sleep apnea, including cardiovascular disease and metabolic disorders, is further supporting device adoption. As sleep medicine becomes an increasingly recognized healthcare specialty, demand for effective treatment solutions is expected to rise throughout the region.

In February 2024, ResMed launched its AirCurve 11 series bilevel devices, featuring advanced digital health capabilities, cloud connectivity, and personalized therapy support to improve sleep apnea treatment adherence and patient outcomes.

Technological Advancements in Sleep Apnea Therapy Solutions

Continuous innovation in sleep apnea treatment technologies is accelerating market growth across Asia Pacific. Manufacturers are focusing on improving patient comfort, portability, connectivity, and ease of use to enhance long-term therapy compliance. Modern devices increasingly incorporate remote monitoring capabilities, AI-driven coaching tools, smartphone integration, and cloud-based data management platforms that enable healthcare providers to monitor treatment effectiveness. Advancements in mask design, pressure delivery systems, and personalized therapy settings are helping reduce treatment discontinuation rates. These innovations are making sleep apnea therapy more convenient and accessible for patients while improving clinical outcomes and healthcare efficiency.

In April 2024, Fisher & Paykel Healthcare introduced the F&P Nova Micro(TM), its smallest and lightest nasal pillows mask for obstructive sleep apnea treatment. The compact design focuses on enhanced comfort, freedom of movement, and improved patient acceptance of PAP therapy.

Growing Adoption of Digital Health and Wearable Sleep Monitoring Technologies

The increasing integration of digital health technologies and wearable devices into sleep disorder management is creating new opportunities for market growth. Consumers are becoming more proactive about monitoring sleep quality, leading to greater adoption of connected health solutions capable of detecting sleep abnormalities. Wearable technologies provide convenient screening and monitoring capabilities that can encourage earlier diagnosis and treatment initiation. Healthcare providers are also leveraging digital platforms to improve patient engagement, remote monitoring, and therapy adherence. As digital healthcare ecosystems continue to expand across Asia Pacific, demand for connected sleep apnea management solutions is expected to increase significantly.

In June 2025, Samsung expanded the availability of its Sleep Apnea feature for Galaxy Watch devices to additional international markets, including Australia, enabling wearable-based identification of signs associated with obstructive sleep apnea through the Samsung Health Monitor platform.

Challenges in the Asia Pacific Sleep Apnea Devices Market

Low Diagnosis and Treatment Rates

Despite the growing prevalence of sleep apnea across Asia Pacific, a substantial proportion of affected individuals remain undiagnosed. Limited awareness regarding sleep disorders, lack of routine screening, and insufficient access to sleep laboratories contribute to delayed diagnosis and treatment. Many patients mistake symptoms such as snoring, daytime fatigue, and poor sleep quality for normal lifestyle-related issues, resulting in underreporting and undertreatment. In several emerging economies, sleep medicine remains a developing specialty with limited specialist availability. Consequently, many individuals continue to live with untreated sleep apnea, reducing the potential patient pool for device manufacturers. Addressing awareness gaps and expanding diagnostic capabilities remain critical challenges for market growth.

High Device Costs and Compliance Issues

The relatively high cost of CPAP, BiPAP, and advanced sleep apnea treatment devices continues to limit adoption in several Asia Pacific countries. Limited reimbursement coverage and out-of-pocket healthcare expenditures can create affordability barriers for patients requiring long-term therapy. Additionally, treatment adherence remains a significant challenge, as some patients experience discomfort associated with masks, pressure settings, noise, or lifestyle adjustments. Poor compliance can reduce treatment effectiveness and discourage continued device usage. Manufacturers are investing in more comfortable masks, quieter systems, and digital coaching tools to address these concerns. However, balancing affordability with technological innovation remains an ongoing challenge across diverse healthcare markets within the region.

China Sleep Apnea Devices Market

China represents one of the largest opportunities within the Asia Pacific sleep apnea devices market due to its large population, rising prevalence of obesity, and growing awareness of sleep-related breathing disorders. Increasing investments in healthcare infrastructure and expanding access to sleep diagnostic services are contributing to greater adoption of sleep apnea treatment solutions. Demand for home-based respiratory care devices and digital healthcare technologies is also increasing across the country. Government initiatives supporting chronic disease management and healthcare modernization further strengthen market growth. As awareness regarding the long-term health consequences of untreated sleep apnea continues to rise, demand for innovative diagnostic and monitoring technologies is expected to increase throughout China.

In March 2024, The Sleep Medicine Center at China Medical University Hospital launched iDREAM (Intelligent Detection of Respiratory Events through Automated Monitoring), integrating Quanta's QOCA Portable ECG Monitoring Device to support home-based detection and monitoring of sleep apnea symptoms.

Japan Sleep Apnea Devices Market

Japan's sleep apnea devices market is supported by a rapidly aging population, advanced healthcare infrastructure, and increasing awareness of sleep-related health conditions. The country has a well-established sleep medicine ecosystem with widespread access to diagnostic and therapeutic services. Demand for CPAP systems, sleep monitoring devices, and connected healthcare technologies continues to grow as healthcare providers focus on improving long-term disease management. The adoption of digital health platforms and remote patient monitoring solutions is further enhancing treatment effectiveness and patient adherence. Additionally, the increasing emphasis on preventive healthcare and quality-of-life improvement among elderly populations continues to support market expansion. Technological innovation remains a key factor shaping the development of Japan's sleep apnea devices market.

In October 2024, ResMed introduced the AirTouch N30i, a tube-up CPAP mask featuring a ComfiSoft(TM) cushion that combines fabric softness with silicone stability to improve comfort and enhance therapy adherence among sleep apnea patients.

India Sleep Apnea Devices Market

India's sleep apnea devices market is expanding due to increasing awareness of sleep disorders, rising obesity prevalence, growing healthcare expenditure, and improving access to diagnostic services. Rapid urbanization and changing lifestyles have contributed to a growing burden of obstructive sleep apnea, particularly among middle-aged and elderly populations. The increasing adoption of home healthcare solutions and expanding availability of sleep clinics are further supporting market growth. Demand for CPAP and BiPAP devices is increasing as healthcare providers focus on early diagnosis and treatment. Additionally, digital health technologies and remote patient monitoring solutions are enhancing therapy compliance and patient engagement. The growing emphasis on respiratory health and sleep disorder management is expected to continue driving demand for advanced sleep apnea devices across India.

In January 2025, ResMed launched the AirSense 11 in India, a next-generation CPAP device featuring Personal Therapy Assistant and Care Check-In functions that provide personalized guidance to help patients initiate and maintain sleep apnea therapy.

Australia Sleep Apnea Devices Market

Australia is a mature market for sleep apnea devices, supported by strong healthcare infrastructure, high awareness of sleep disorders, and widespread adoption of home-based respiratory care solutions. Rising obesity rates and increasing prevalence of sleep-disordered breathing continue to drive demand for diagnostic and therapeutic devices. Healthcare providers are increasingly utilizing digital monitoring technologies and connected treatment platforms to improve patient outcomes and therapy compliance. The country's focus on preventive healthcare and chronic disease management further supports market growth. In addition, the growing adoption of wearable health technologies is expanding opportunities for sleep apnea screening and monitoring. Continued technological advancements are expected to strengthen sleep disorder management across Australia.

In May 2025, Australia's Therapeutic Goods Administration (TGA) approved sleep apnea monitoring technology integrated into Apple Watch and Samsung Galaxy Watch devices, enabling wearable-based sleep apnea monitoring and supporting broader adoption of digital sleep health solutions in the country.

Asia Pacific CPAP Sleep Apnea Therapeutic Devices Market

The CPAP (Continuous Positive Airway Pressure) therapeutic devices segment represents a significant share of the Asia Pacific sleep apnea devices market due to its widespread use as the first-line treatment for obstructive sleep apnea. CPAP devices deliver a continuous stream of pressurized air to keep the airway open during sleep, helping reduce breathing interruptions and improve sleep quality. Growing awareness of sleep disorders, rising obesity rates, and increasing diagnosis of obstructive sleep apnea are supporting demand for CPAP therapy across the region. Technological advancements such as automated pressure adjustment, cloud-based monitoring, smartphone connectivity, and improved mask comfort are enhancing patient adherence. Expanding healthcare access and increasing adoption of home-based sleep apnea management solutions further contribute to growth in the CPAP devices segment.

Asia Pacific Actigraphy Monitoring Device Market

The actigraphy monitoring device segment is gaining importance within the Asia Pacific sleep apnea devices market as healthcare providers increasingly emphasize early diagnosis and long-term sleep monitoring. Actigraphy devices use wearable sensors to track movement patterns, sleep duration, and sleep-wake cycles, providing valuable insights into sleep behavior. These devices are widely used in sleep studies, screening programs, and home-based monitoring applications. Growing consumer interest in digital health technologies and wearable health devices is accelerating adoption across the region. Additionally, healthcare professionals are utilizing actigraphy as a convenient and cost-effective tool for evaluating sleep disorders and monitoring treatment outcomes. Continuous advancements in sensor technology, wireless connectivity, and data analytics are further supporting the expansion of the actigraphy monitoring device market.

Asia Pacific Sleep Laboratories, Clinics & Hospitals Market

Sleep laboratories, clinics, and hospitals constitute a major end-user segment within the Asia Pacific sleep apnea devices market. These healthcare facilities play a critical role in the diagnosis, treatment, and management of sleep-related breathing disorders. Sleep laboratories conduct comprehensive diagnostic studies, including polysomnography and respiratory monitoring, while specialized clinics provide patient evaluation, therapy initiation, and follow-up care. Hospitals remain key centers for managing complex sleep apnea cases and associated comorbidities. Increasing awareness of sleep disorders, expanding healthcare infrastructure, and growing availability of sleep medicine specialists are driving demand for diagnostic and therapeutic services across the region. Furthermore, investments in advanced diagnostic technologies and integrated sleep care programs are strengthening the role of sleep laboratories, clinics, and hospitals in sleep apnea management.

Asia Pacific Sleep Apnea Devices Market Type:

Type

• Therapeutic Devices
• Diagnostic Devices

Therapeutic Devices

• CPAP Sleep Apnea Therapeutic Devices
• Auto CPAP Sleep Apnea Therapeutic Devices
• BiPAP Sleep Apnea Therapeutic Devices
• Adaptive Servo-Ventilation (ASV)

Diagnostic Devices

• Polysomnography Devices(PSG)
• Oximeter
• Actigraphy Monitoring Device
• Respiratory Polygraph
• Sleep Apnea Screening Device

End User

• Sleep Laboratories, Clinics & Hospitals
• Home Care Settings/Individuals

Countries

• China
• Japan
• India
• South Korea
• Thailand
• Malaysia
• Indonesia
• Australia
• New Zealand
• Rest of Asia Pacific

All companies have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Key Players Analysis

• Resmed Inc
• Koninklijke Philips NV
• Fisher & Paykel Healthcare Corporatn Ltd
• Nihon Kohden Corp
• Wellell Inc
• BMC Medical Co Ltd
• Compumedics Ltd
• Inspire Medical Systems Inc.